# Nutricia UK Ltd clinical trials: 28 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 28 trials with Nutricia UK Ltd as lead sponsor, 5 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Nutricia UK Ltd: 28 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/nutricia-uk-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 29, 2026 | NCT07734532 | Infant Formula Study With Pre- And Postbiotics | Nutricia UK Ltd | Not applicable | Completed | Formula Milk, Infants | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734532) |
| June 26, 2026 | NCT07671859 | PKU Microtablets Case Studies | Nutricia UK Ltd | Not applicable | Not yet recruiting | Phenylketonuria (PKU) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07671859) |
| February 20, 2026 | NCT07422935 | Plant-Protein Dominant Tube Feed Study | Nutricia UK Ltd | Not applicable | Recruiting | Enteral Nutrition (Food for Special Medical Purposes), Enteral Feeds | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422935) |
| April 23, 2025 | NCT06941532 | GMP Powdered Substitutes in PKU and TYR | Nutricia UK Ltd | Not applicable | Recruiting | Phenylketonuria, Tyrosinemia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06941532) |
| March 14, 2025 | NCT06877923 | Elemental 028 Extra Case Studies | Nutricia UK Ltd | Not applicable | Recruiting | Gastrointestinal Disease, Inflammatory Bowel Disease (IBD), Short Bowel, Malabsorption, Allergies, Neurodegenerative... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06877923) |
| March 1, 2024 | NCT06288503 | Hydrolysed Rice Formula Study | Nutricia UK Ltd | Not applicable | Recruiting | Cow's Milk Protein Allergy | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06288503) |
| April 20, 2023 | NCT05822557 | Bolus Pouch Feed Study | Nutricia UK Ltd | Not applicable | Completed | Cancer, Neurological Disorder, Gastrointestinal Dysfunction, Oral Complication, Stroke | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05822557) |
| June 9, 2022 | NCT05411848 | 2kcal Tube Feed Study | Nutricia UK Ltd | Not applicable | Completed | Enteral Nutrition, Cancer | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05411848) |
| March 8, 2022 | NCT05269992 | Childrens Real Food Tolerance Study | Nutricia UK Ltd | Not applicable | Active not recruiting | Malnutrition, Child | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05269992) |
| February 25, 2022 | NCT05257980 | Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial | Nutricia UK Ltd | Not applicable | Active not recruiting | Malnutrition | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05257980) |
| September 30, 2021 | NCT05062226 | GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR | Nutricia UK Ltd | Not applicable | Completed | PKU, Tyrosinemias | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05062226) |
| September 27, 2021 | NCT05057390 | HMF Preterm Case Studies | Nutricia UK Ltd | Not applicable | Completed | Preterm Infants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05057390) |
| September 16, 2021 | NCT05046418 | Synbiotics Cohort Study | Nutricia UK Ltd | Observational | Terminated | Cows Milk Allergy | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05046418) |
| October 29, 2020 | NCT04607330 | Protein Top-up Acceptability Study for Patients With Increased Protein Needs | Nutricia UK Ltd | Not applicable | Completed | Cancer, Neurological Injury, Respiratory Disease, Stroke | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04607330) |
| February 17, 2020 | NCT04272736 | PKU Low Calorie Drink Study | Nutricia UK Ltd | Not applicable | Withdrawn | Phenylketonurias, Hyperphenylalaninaemia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04272736) |
| March 14, 2019 | NCT03874104 | Synbiotic Extensively Hydrolysed Feed Study | Nutricia UK Ltd | Not applicable | Completed | Cow Milk Allergy | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03874104) |
| September 20, 2018 | NCT03679078 | IDDSI Nutritional Drink for Dysphagia Study | Nutricia UK Ltd | Not applicable | Suspended | Dysphagia, Malnutrition | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03679078) |
| November 7, 2017 | NCT03333720 | Compliance, Tolerance and Acceptability of a Tablet Protein Substitute for the Dietary Management of Phenylketonuria | Nutricia UK Ltd | Not applicable | Withdrawn | Phenylketonurias | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03333720) |
| June 22, 2017 | NCT03196271 | Ketogenic Diet Drink Study | Nutricia UK Ltd | Not applicable | Completed | Intractable Epilepsy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03196271) |
| May 30, 2017 | NCT03168243 | High Energy High Protein Tube Feed Study | Nutricia UK Ltd | Not applicable | Completed | Nutrition | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03168243) |
| May 30, 2017 | NCT03167697 | Evaluating the Efficacy of PKU Synergy in Patients Expressing Phenylketonuria or Hyperphenylalaninemia | Nutricia UK Ltd | Not applicable | Completed | Phenylketonurias, Hyperphenylalaninaemia, Type I | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03167697) |
| May 4, 2017 | NCT03140371 | High Energy High Protein Peptide Feed Study | Nutricia UK Ltd | Not applicable | Completed | Malnutrition, Malabsorption | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03140371) |
| September 27, 2016 | NCT02915510 | GMP Drink for PKU Study | Nutricia UK Ltd | Not applicable | Completed | Phenylketonuria | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02915510) |
| October 7, 2015 | NCT02569840 | Amino Acid Feed Children's Study | Nutricia UK Ltd | Not applicable | Completed | Milk Hypersensitivity | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02569840) |
| April 17, 2015 | NCT02419599 | High vs Standard Energy Children's Drink Study | Nutricia UK Ltd | Not applicable | Completed | Growth Failure | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02419599) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 1 |
| Not applicable | 26 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Recruiting | 4 |
| Active not recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
| Suspended | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Malnutrition | 6 |
| Phenylketonurias | 6 |
| Milk Hypersensitivity | 4 |
| Neoplasms | 3 |
| Malabsorption Syndromes | 2 |
| Stroke | 2 |
| Tyrosinemias | 2 |
| Nervous System Diseases | 1 |
| Gastrointestinal Diseases | 1 |
| Inflammatory Bowel Diseases | 1 |
| Hypersensitivity | 1 |
| Neurodegenerative Diseases | 1 |
| Trauma, Nervous System | 1 |
| Respiration Disorders | 1 |
| Deglutition Disorders | 1 |
| Child Nutrition Disorders | 1 |
| Failure to Thrive | 1 |
| Drug Resistant Epilepsy | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Energy management companies in the United States](https://specstream.ai/data/businesses/energy-management-companies/united-states)
- [Food and beverage distributors in the United States](https://specstream.ai/data/businesses/food-and-beverage-distributors/united-states)
- [High schools in the United States](https://specstream.ai/data/businesses/high-schools/united-states)
- [Internal medicine practices in the United States](https://specstream.ai/data/businesses/internal-medicine-practices/united-states)
- [Livestock feed and supply stores in the United States](https://specstream.ai/data/businesses/livestock-feed-and-supply-stores/united-states)
- [Mortgage lenders in the United States](https://specstream.ai/data/businesses/mortgage-lenders/united-states)
